BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3012992)

  • 1. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
    Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
    Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
    Erhardt K; Auer GU
    Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
    Azavedo E; Fallenius A; Svane G; Auer G
    Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
    von Rosen A; Fallenius A; Sundelin B; Auer G
    Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic impact of cytochemically assessed nuclear DNA contents in human adenocarcinomas of the mammary gland.
    Askensten U
    Arch Geschwulstforsch; 1988; 58(6):431-9. PubMed ID: 3066302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.
    Toikkanen S; Eerola E; Ekfors TO
    J Clin Pathol; 1988 Mar; 41(3):300-3. PubMed ID: 2834422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of DNA measurements in a histologically defined subset of infiltrating ductal carcinomas of the breast with long-term follow-up.
    Troncoso P; Dytch HE; Bibbo M; Wied GL; Dawson PJ
    Anal Quant Cytol Histol; 1989 Jun; 11(3):166-72. PubMed ID: 2545218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
    Bogatyrev VN; Ermilova VD; Petrova AS
    Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between slide and flow cytophotometric DNA measurements in breast tumors.
    Auer GU; Askensten U; Erhardt K; Fallenius A; Zetterberg A
    Anal Quant Cytol Histol; 1987 May; 9(2):138-46. PubMed ID: 3606774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochemical classification of nonpalpable breast carcinoma.
    Fallenius A; Svane G; Auer G; Caspersson TO
    Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of quantitative biological cell parameters in the handling of mammary carcinoma.
    Theve NO; Azavedo E; Blomstedt B; Wiking N; Auer GU
    Acta Chir Scand; 1982; 148(3):239-41. PubMed ID: 6291293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyometric and DNA content analyses of cancer cells in stage III breast cancer with reference to prognosis.
    Tamura G; Masuda T; Satoh T; Satodate R; Ishida M; Saitoh K
    Jpn J Clin Oncol; 1990 Mar; 20(1):78-82. PubMed ID: 2157083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma.
    Herrera MF; van Heerden JA; Katzmann JA; Weiland LH; Nagorney DM; Ilstrup D
    Ann Surg; 1992 Feb; 215(2):120-4. PubMed ID: 1312318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
    Toikkanen S; Joensuu H; Klemi P
    Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary carcinoma: DNA analysis in areas showing different histological features in the same tumor.
    Erhardt K; Auer G
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):21-8. PubMed ID: 3515846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative DNA measurements of ductal pancreatic cancers: comparison of the DNA content with histology, rate of survival, grading and staging].
    Weger AR; Graf AH; Askensten U; Schwab G; Bodner E; Auer G; Mikuz G
    Verh Dtsch Ges Pathol; 1987; 71():126-9. PubMed ID: 2830735
    [No Abstract]   [Full Text] [Related]  

  • 20. Feulgen DNA cytophotometry in histologic sections of mammary neoplasms.
    Berryman I; Sterrett GF; Papadimitriou JM
    Anal Quant Cytol; 1984 Mar; 6(1):19-23. PubMed ID: 6732070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.